Personal Therapy Assistant feature for AirSense 11 users, seen here within the myAir app SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ResMed, a global leader in digital health and sleep apnea ...
Resmed has received clearance from the U.S. Food and Drug Administration (FDA) for an artificial intelligence (AI)-enabled device that recommends personalized comfort settings to help people with obst ...
ResMed Inc. RMD recently launched AirSense 11, the company’s next-generation PAP (positive airway pressure) device. AirSense 11 is available in the United States, with other countries to follow, and ...
Sleep apnea has become a global health concern, affecting millions of people and leading to fatigue, cardiovascular disease, and other chronic health issues. To address this widespread problem, ResMed ...
ResMed, the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, has launched AirSense 11 in India. The company’s next-generation Continuous Positive ...
ResMed Inc. RMD recently launched AirSense 11, the company’s next-generation PAP (positive airway pressure) device. AirSense 11 is available in the United States, with other countries to follow, and ...
SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ResMed, a global leader in digital health and sleep apnea treatment, (NYSE: RMD, ASX: RMD) today launched AirSense 11, available first in the U.S., the ...
ResMed Inc. RMD recently launched AirSense 11, the company’s next-generation PAP (positive airway pressure) device. AirSense 11 is available in the United States, with other countries to follow, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback